Matches in Wikidata for { <http://www.wikidata.org/entity/Q93089435> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q93089435 description "article scientifique publié en 2019" @default.
- Q93089435 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q93089435 description "scientific article published on 03 September 2019" @default.
- Q93089435 description "wetenschappelijk artikel" @default.
- Q93089435 description "наукова стаття, опублікована 3 вересня 2019" @default.
- Q93089435 name "Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review" @default.
- Q93089435 name "Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review" @default.
- Q93089435 type Item @default.
- Q93089435 label "Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review" @default.
- Q93089435 label "Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review" @default.
- Q93089435 prefLabel "Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review" @default.
- Q93089435 prefLabel "Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review" @default.
- Q93089435 P1433 Q93089435-FEBEE082-2A52-4A72-AF3D-4EAEAA192D5B @default.
- Q93089435 P1476 Q93089435-5D7B57EA-6A56-4D1A-8533-3DE025546A7A @default.
- Q93089435 P2093 Q93089435-139B57F6-1F05-4433-A8DE-70368816F2EA @default.
- Q93089435 P2093 Q93089435-1827F028-345B-4C9E-B1A4-A55BEA921E57 @default.
- Q93089435 P2093 Q93089435-41E4570F-95E9-4785-B8FA-A59EB96ACF26 @default.
- Q93089435 P2093 Q93089435-570C2AC8-78D1-45CF-BC8D-594E407E10F6 @default.
- Q93089435 P2093 Q93089435-85795964-8A4D-4D3F-80C7-49CD0FDB94FE @default.
- Q93089435 P2507 Q93089435-AA1FD1FE-40CB-4C92-AAF3-E884EBD4AB0B @default.
- Q93089435 P31 Q93089435-B98C9533-0C87-4D91-B440-171D38D3BB34 @default.
- Q93089435 P31 Q93089435-ff6e9ecd-d4d2-49ee-8165-7bf8a05fdb10 @default.
- Q93089435 P356 Q93089435-37380E45-D1E3-499B-98E8-9BF562AC3187 @default.
- Q93089435 P50 Q93089435-43F6BCF3-55A3-4FFD-BA1A-BA73225ACE4A @default.
- Q93089435 P577 Q93089435-4A278659-7178-411C-A4EF-28E986986621 @default.
- Q93089435 P698 Q93089435-FDE48526-7ED0-4C07-B2F8-1B9A7D4BFFFB @default.
- Q93089435 P921 Q93089435-339DFE91-B505-487F-BB92-656F256088B1 @default.
- Q93089435 P921 Q93089435-36A42CEF-4BA4-4649-92B0-AAF43AB8198E @default.
- Q93089435 P356 S00415-019-09498-4 @default.
- Q93089435 P698 31482201 @default.
- Q93089435 P1433 Q6295649 @default.
- Q93089435 P1476 "Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review" @default.
- Q93089435 P2093 "Anu Jacob" @default.
- Q93089435 P2093 "B Paul Morgan" @default.
- Q93089435 P2093 "Daniel H Whittam" @default.
- Q93089435 P2093 "Marcelo Matiello" @default.
- Q93089435 P2093 "Saif Huda" @default.
- Q93089435 P2507 Q90785679 @default.
- Q93089435 P31 Q13442814 @default.
- Q93089435 P31 Q7318358 @default.
- Q93089435 P356 "10.1007/S00415-019-09498-4" @default.
- Q93089435 P50 Q90785677 @default.
- Q93089435 P577 "2019-09-03T00:00:00Z" @default.
- Q93089435 P698 "31482201" @default.
- Q93089435 P921 Q611458 @default.
- Q93089435 P921 Q8285 @default.